Question for Dr T, I completely understand if this is price sensitive or unable to be answered at this time.
Is there a plan for what the money will be used for from (hopefully) the $4.50 option conversions, or will this just be a top up for the company to stay healthy financially going forward?
This discussion has me thinking; of all the different opportunities for Zantrene, is there a plan or ranking of what is highest priority for extra trials going forward once this money (hopefully) starts trickling in?
Thanks!
Question for Dr T, I completely understand if this is price...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.025(1.99%) |
Mkt cap ! $204.3M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.21 | $72.87K | 59.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11868 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 556 | 1 |
View Market Depth
| Last trade - 13.41pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.025 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.25 | $1.25 | $1.21 | 14744 | ||
| Last updated 13.41pm 01/05/2024 ? | |||||
| RAC (ASX) Chart |